Will the sequester's cancer cuts get fixed?
Medicare said Thursday that it does not have the power to reverse automatic spending cuts that are causing cancer clinics to turn away thousands of patients. "We are unaware of any authority that could exempt Part B drugs from the sequestration requirements," Medicare spokesman Brian Cook said. The sequester is a series of across-the-board budget reductions that Congress allowed to go into effect when it could not agree on a spending plan earlier this year. As an unexpected consequence of the sequester's cut to Medicare, cancer clinics are finding that they cannot afford to continue administering some chemotherapy drugs.
- Ratcheting Up Patient Experience Has a Downside
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Narrow Networks Enjoying a Resurgence
- Physicians Trained in High-Cost Regions Spend More
- HL20: Anne Wojcicki—Unlocking Consumer Access to Genetics
- Christmas Tree Syndrome Season Underway
- HL20: Lee Aase—Who's Behind @MayoClinic
- HL20: Tom X. Lee, MD—Reinventing Primary Care
- Population Health Starts with Ending Hunger
- HL20: José Ramón Fernández-Peña, MD, MPA—A Welcoming Approach